Thomas Frist - Science Applications Independent Director
SAIC Stock | USD 129.84 0.88 0.68% |
Director
Mr. Thomas F. Frist, III is Independent Director of Science Applications International Corporationration Mr. Frist is a principal of Frist Capital LLC, a private investment vehicle for Mr. Frist and certain related persons, and has held this position since 1994. Prior to that, he comanaged FS Partners, LLC and worked at Rainwater, Inc. in Fort Worth, Texas and in New York. Since 2006, Mr. Frist has served on the Board of Directors of HCA Holdings, Inc., one of the largest nongovernmental operators of health care facilities in the United States. He was previously a director of Leidos Holdings, Inc. from 2009 until September 2013 and of Triad Hospitals, Inc. from 1999 to 2006. since 2013.
Age | 47 |
Tenure | 11 years |
Address | 12010 Sunset Hills Road, Reston, VA, United States, 20190 |
Phone | 703 676 4300 |
Web | https://www.saic.com |
Science Applications Management Efficiency
The company has return on total asset (ROA) of 0.0604 % which means that it generated a profit of $0.0604 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2734 %, meaning that it created $0.2734 on every $100 dollars invested by stockholders. Science Applications' management efficiency ratios could be used to measure how well Science Applications manages its routine affairs as well as how well it operates its assets and liabilities. As of May 3, 2024, Return On Tangible Assets is expected to decline to 0.12. In addition to that, Return On Capital Employed is expected to decline to 0.10. At present, Science Applications' Total Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 155.8 M, whereas Total Assets are forecasted to decline to about 4.7 B.Similar Executives
Showing other executives | DIRECTOR Age | ||
Richard Massey | Fidelity National Information | 59 | |
David Hunt | Fidelity National Information | 72 | |
Thomas Wimsett | Jack Henry Associates | 54 | |
Keith Hughes | Fidelity National Information | 73 | |
Louise Parent | Fidelity National Information | 69 | |
Alexander Navab | Fidelity National Information | ||
Stephan James | Fidelity National Information | 71 | |
Laura Kelly | Jack Henry Associates | 60 | |
Thomas Wilson | Jack Henry Associates | 57 | |
James Stallings | Fidelity National Information | 65 | |
Jacqueline Fiegel | Jack Henry Associates | 63 | |
Thomas Hagerty | Fidelity National Information | 53 | |
Ellen Alemany | Fidelity National Information | 65 | |
Lisa Hook | Fidelity National Information | 63 | |
Shruti Miyashiro | Jack Henry Associates | 46 | |
Brian Shea | Fidelity National Information | 60 | |
Gary Lauer | Fidelity National Information | 67 | |
Wesley Brown | Jack Henry Associates | 63 | |
Jeffrey Stiefler | Fidelity National Information | 73 | |
Lee Adrean | Fidelity National Information | 67 | |
Leslie Muma | Fidelity National Information | 73 |
Management Performance
Return On Equity | 0.27 | ||||
Return On Asset | 0.0604 |
Science Applications Leadership Team
Elected by the shareholders, the Science Applications' board of directors comprises two types of representatives: Science Applications inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Science. The board's role is to monitor Science Applications' management team and ensure that shareholders' interests are well served. Science Applications' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Science Applications' outside directors are responsible for providing unbiased perspectives on the board's policies.
Edward Sanderson, Independent Chairman of the Board | ||
Dorothy Helfenstein, Executive Vice President Chief Strategic Growth Officer | ||
Charles Mathis, CFO, Executive Vice President | ||
David Kerko, Director | ||
Yvette Kanouff, Independent Director | ||
Steven Mahon, Executive Vice President, General Counsel, Secretary | ||
Donna Morea, Non-Executive Independent Chairman of the Board | ||
Nathan Rogers, Chief Officer | ||
Hilary Hageman, General VP | ||
Douglas Wagoner, Sector President of Services and Solutions | ||
Joseph DeNardi, Vice Relations | ||
John Bonsell, Senior Affairs | ||
Prabu Natarajan, Chief Financial Officer, Executive Vice President | ||
Garth Graham, Independent Director | ||
Robert Genter, Executive Vice President and General Manager - Civilian Markets Group | ||
John Hartley, CFO and Executive VP | ||
Nazzic Keene, Sector President of Global Markets and Missions | ||
Mark Escobar, Executive Operations | ||
Robert Bedingfield, Independent Director | ||
Steven Shane, Independent Director | ||
Milford McGuirt, Director | ||
Paul Levi, Sr. VP, Director of Investor Relations and Corporate Fin. and Treasurer | ||
Shane Canestra, Director of Investor Relations | ||
Catherine HernandezBlades, Senior Communications | ||
Kimberly Admire, Chief HR Officer and Executive VP | ||
Deborah Dunie, Director | ||
Michelle OHara, Chief Human Resource Officer, Executive Vice President | ||
Karen Wheeler, Chief Human Resource Officer | ||
Paul Greiner, Senior Counsel | ||
Michael LaRouche, Executive Vice President and General Manager - National Security Group | ||
Toni TownesWhitley, CEO Director | ||
Anthony Moraco, CEO, Director, Member of Ethics and Corporate Responsibility Committee and Member of Classified Bus. Oversight Committee | ||
Maria Bishop, Interim CFO, Interim Principal Accounting Officer and Interim Principal Financial Officer | ||
Lucy Fitch, Chief VP | ||
Thomas Frist, Independent Director | ||
Katharina McFarland, Independent Director | ||
Carol Goode, Independent Director | ||
Mark Johnson, Director | ||
John Hamre, Independent Director | ||
Timothy Mayopoulos, Independent Director |
Science Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Science Applications a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.27 | ||||
Return On Asset | 0.0604 | ||||
Profit Margin | 0.06 % | ||||
Operating Margin | 0.05 % | ||||
Current Valuation | 8.85 B | ||||
Shares Outstanding | 51.27 M | ||||
Shares Owned By Insiders | 0.87 % | ||||
Shares Owned By Institutions | 79.26 % | ||||
Number Of Shares Shorted | 515.88 K | ||||
Price To Earning | 30.77 X |
Science Applications Investors Sentiment
The influence of Science Applications' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Science. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Science Applications' public news can be used to forecast risks associated with an investment in Science. The trend in average sentiment can be used to explain how an investor holding Science can time the market purely based on public headlines and social activities around Science Applications International. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Science Applications' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Science Applications' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Science Applications' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Science Applications.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Science Applications in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Science Applications' short interest history, or implied volatility extrapolated from Science Applications options trading.
Currently Active Assets on Macroaxis
When determining whether Science Applications offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Science Applications' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Science Applications International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Science Applications International Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Science Stock analysis
When running Science Applications' price analysis, check to measure Science Applications' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science Applications is operating at the current time. Most of Science Applications' value examination focuses on studying past and present price action to predict the probability of Science Applications' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Science Applications' price. Additionally, you may evaluate how the addition of Science Applications to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Science Applications' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Applications. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Applications listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.45) | Dividend Share 1.48 | Earnings Share 8.88 | Revenue Per Share 140.188 | Quarterly Revenue Growth (0.12) |
The market value of Science Applications is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Applications' value that differs from its market value or its book value, called intrinsic value, which is Science Applications' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Applications' market value can be influenced by many factors that don't directly affect Science Applications' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Science Applications' value and its price as these two are different measures arrived at by different means. Investors typically determine if Science Applications is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Applications' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.